Joseph A Lewnard
Overview
Explore the profile of Joseph A Lewnard including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
113
Citations
2968
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tan S, Rodriguez-Barraquer I, Kwan A, Blumberg S, Park H, Hutchinson J, et al.
Nat Commun
. 2025 Jan;
16(1):1090.
PMID: 39881133
Early investigation revealed a reduced risk of SARS-CoV-2 infection among social contacts of COVID-19 vaccinated individuals, referred to as indirect protection. However, indirect protection from SARS-CoV-2 infection-acquired immunity and its...
2.
King L, Andrejko K, Kobayashi M, Xing W, Cohen A, Self W, et al.
medRxiv
. 2024 Dec;
PMID: 39711720
Background: (pneumococcus) causes invasive pneumococcal disease (IPD) and non-invasive acute respiratory infections (ARIs). Three pneumococcal conjugate vaccines (PCVs) are recommended in the United States with additional products in clinical trials....
3.
Tartof S, Aliabadi N, Goodwin G, Slezak J, Hong V, Ackerson B, et al.
JAMA Netw Open
. 2024 Dec;
7(12):e2450832.
PMID: 39671195
Importance: Clinical trials have demonstrated high vaccine efficacy (VE) against lower respiratory tract disease (LRTD) but enrolled a smaller proportion of persons aged 75 years or older and those with...
4.
Rogawski McQuade E, Brennhofer S, Elwood S, Lewnard J, Liu J, Houpt E, et al.
Lancet Glob Health
. 2024 Nov;
12(12):e1954-e1961.
PMID: 39577969
Background: Vaccines for diarrhoea could have the ancillary benefit of preventing antibiotic use. We aimed to quantify and compare the expected impact of enteric vaccines on antibiotic use via Monte...
5.
Lewnard J, Mahale P, Malden D, Hong V, Ackerson B, Lewin B, et al.
Nat Commun
. 2024 Oct;
15(1):8550.
PMID: 39362845
The SARS-CoV-2 BA.2.86 lineage, and its sublineage JN.1 in particular, achieved widespread transmission in the US during winter 2023-24. However, this surge in infections was not accompanied by COVID-19 hospitalizations...
6.
King L, Lewnard J
Vaccine
. 2024 Sep;
42(26):126310.
PMID: 39260055
Introduction: Next-generation pneumococcal vaccines currently in clinical trials include 24- and 31-valent pneumococcal conjugate vaccines (PCV24, PCV31), which aim to prevent upper-respiratory carriage and disease involving the targeted serotypes. We...
7.
Tan S, Rodriguez-Barraquer I, Kwan A, Blumberg S, Park H, Hutchinson J, et al.
medRxiv
. 2024 Aug;
PMID: 39211889
Early investigation revealed that COVID-19 vaccines confer indirect protection to fully susceptible and unvaccinated persons, defined as a reduced risk of SARS-CoV-2 infection among social contacts of vaccinated individuals. However,...
8.
Lewnard J, Hong V, Grant L, Ackerson B, Bruxvoort K, Pomichowski M, et al.
J Infect Dis
. 2024 Aug;
230(5):e1082-e1091.
PMID: 39101606
Background: Pneumococcal carriage is associated with increased acquisition and duration of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection among adults. While pneumococcal conjugate vaccines (PCVs) prevent carriage of vaccine-serotype...
9.
Parker A, Jackson N, Awasthi S, Kim H, Alwan T, Wyllie A, et al.
Microbiol Spectr
. 2024 Jul;
12(8):e0087924.
PMID: 39012111
Most pneumococcal disease occurs among infants and older adults and is thought to be driven by the transmission of from young children to these vulnerable age groups. However, pneumococcal disease...
10.
Lewnard J, Charani E, Gleason A, Hsu L, Khan W, Karkey A, et al.
Lancet
. 2024 May;
403(10442):2439-2454.
PMID: 38797180
National action plans enumerate many interventions as potential strategies to reduce the burden of bacterial antimicrobial resistance (AMR). However, knowledge of the benefits achievable by specific approaches is needed to...